Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asthma Exacerbation Profile on Benralizumab
2018-003699-11Phase 4Unknown
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Nov 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of benralizumab in eosinophilic asthma (EA), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Inflammatory and physiological characteristics of asthma exacerbation during benralizumab treatment. Status: unknown.
02
Drugs
benralizumab
03
Conditions
eosinophilic asthma (EA)
Beyond the preview
Go deeper on 2018-003699-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003699-11.